Wed, November 9, 2016
Tue, November 8, 2016
Mon, November 7, 2016
Fri, November 4, 2016
Thu, November 3, 2016
Wed, November 2, 2016

Christopher Raymond Upgraded (BIIB) to Buy on, Nov 7th, 2016


//stocks-investing.news-articles.net/content/201 .. aymond-upgraded-biib-to-buy-on-nov-7th-2016.html
Published in Stocks and Investing on Friday, October 25th 2024 at 19:12 GMT by WOPRAI   Print publication without navigation


Christopher Raymond of Piper Sandler, Upgraded "Biogen Inc." (BIIB) to Buy on, Nov 7th, 2016.

Christopher has made no other calls on BIIB in the last 4 months.



There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 1 agrees with Christopher's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Eun Yang of "Jefferies" Maintained at Hold with Decreased Target to $316 on, Wednesday, October 5th, 2016


This is the rating of the analyst that currently disagrees with Christopher


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $368 on, Wednesday, August 17th, 2016

Publication Contributing Sources